| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Connectomics: A new paradigm for understanding brain disease
|
Fornito, Alex
|
|
2015
|
25 |
5 |
p. 733-748
16 p.
|
article
|
| 2 |
Contents
|
|
|
2015
|
25 |
5 |
p. OBC-
1 p.
|
article
|
| 3 |
Developments in the field of antidepressants, where do we go now?
|
Artigas, Francesc
|
|
2015
|
25 |
5 |
p. 657-670
14 p.
|
article
|
| 4 |
ECNP Calendar of Events
|
|
|
2015
|
25 |
5 |
p. I-
1 p.
|
article
|
| 5 |
Editorial Board
|
|
|
2015
|
25 |
5 |
p. IFC-
1 p.
|
article
|
| 6 |
Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
|
Szyf, Moshe
|
|
2015
|
25 |
5 |
p. 682-702
21 p.
|
article
|
| 7 |
How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?
|
Kempton, Matthew J.
|
|
2015
|
25 |
5 |
p. 725-732
8 p.
|
article
|
| 8 |
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
|
Millan, Mark J.
|
|
2015
|
25 |
5 |
p. 599-656
58 p.
|
article
|
| 9 |
Present and future of developmental neuropsychopharmacology
|
Arango, Celso
|
|
2015
|
25 |
5 |
p. 703-712
10 p.
|
article
|
| 10 |
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
|
Bayer, Thomas A.
|
|
2015
|
25 |
5 |
p. 713-724
12 p.
|
article
|
| 11 |
The current and potential impact of genetics and genomics on neuropsychopharmacology
|
Harrison, Paul J.
|
|
2015
|
25 |
5 |
p. 671-681
11 p.
|
article
|
| 12 |
60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress
|
Millan, Mark J.
|
|
2015
|
25 |
5 |
p. 591-598
8 p.
|
article
|
Journal description